中国实用医刊
中國實用醫刊
중국실용의간
CENTRAL PLAINS MEDICAL JOURNAL
2011年
24期
1-3
,共3页
严丽洁%段红艳%王山岭%李永强%杨海涛%王丽霞
嚴麗潔%段紅豔%王山嶺%李永彊%楊海濤%王麗霞
엄려길%단홍염%왕산령%리영강%양해도%왕려하
阿托伐他汀%亚临床动脉粥样硬化%脉搏波传导速度
阿託伐他汀%亞臨床動脈粥樣硬化%脈搏波傳導速度
아탁벌타정%아림상동맥죽양경화%맥박파전도속도
Atorvastatin%Subclinical atherosclerosis%Pulse wave velocity
目的 探讨阿托伐他汀对亚临床动脉粥样硬化患者脉搏波传导速度( PWV)的影响.方法 根据颈动脉内中膜厚度(IMT)将200例研究对象分为亚临床动脉粥样硬化组(n=143,MT≥0.9 mm)和对照组(n=57,IMT＜0.9 mm),亚临床动脉粥样硬化组随机被分为阿托伐他汀治疗组(n=71)和非阿托伐他汀治疗组(n=72),于0周及8周分别测定脉搏波传导速度.结果 阿托伐他汀能明显降低亚临床动脉粥样硬化组PWV.结论 阿托伐他汀能减缓亚临床动脉粥样硬化的进程.
目的 探討阿託伐他汀對亞臨床動脈粥樣硬化患者脈搏波傳導速度( PWV)的影響.方法 根據頸動脈內中膜厚度(IMT)將200例研究對象分為亞臨床動脈粥樣硬化組(n=143,MT≥0.9 mm)和對照組(n=57,IMT＜0.9 mm),亞臨床動脈粥樣硬化組隨機被分為阿託伐他汀治療組(n=71)和非阿託伐他汀治療組(n=72),于0週及8週分彆測定脈搏波傳導速度.結果 阿託伐他汀能明顯降低亞臨床動脈粥樣硬化組PWV.結論 阿託伐他汀能減緩亞臨床動脈粥樣硬化的進程.
목적 탐토아탁벌타정대아림상동맥죽양경화환자맥박파전도속도( PWV)적영향.방법 근거경동맥내중막후도(IMT)장200례연구대상분위아림상동맥죽양경화조(n=143,MT≥0.9 mm)화대조조(n=57,IMT＜0.9 mm),아림상동맥죽양경화조수궤피분위아탁벌타정치료조(n=71)화비아탁벌타정치료조(n=72),우0주급8주분별측정맥박파전도속도.결과 아탁벌타정능명현강저아림상동맥죽양경화조PWV.결론 아탁벌타정능감완아림상동맥죽양경화적진정.
Objective To observe the influence of atorvastatin on the pulse wave velocity (PWV) in patients with subclinical atherosclerosis.Methods Two hundred patients were divided into sub- clinical group (n =143,IMT≥0.9mm),and control group (n =57,IMT ＜0.9mm),depending on the carotid intima- media thickness (IMT).Subclinical group was randomly divided into atorvastatin group ( n =71 ) and nonatorvastatin group ( n =72).The pulse wave velocity in each group was measured at 0 week and 8 week.Results Atorvastatin can reduce PWV in patients with subclinical atherosclerosis.Conclusions Atorvastatin can slow the process of subclinical atherosclerosis.
